Envista Holdings Corp Stock Price, News & Analysis

DEXIS, a dental imaging technologies leader, reflects on its 2024 achievements and announces plans for 2025. Key 2024 launches included the DEXIS digital ecosystem for streamlined implant workflow, the Ti2 Intraoral Sensor with AI capabilities, DEXIS Connect Pro for proactive device monitoring, and the ORTHOPANTOMOGRAPH OP 3D EX X-ray platform.

The company plans several innovations for 2025, including their first in-house developed intraoral scanner, AI enhancements, 3D imaging portfolio expansion, and DTX Studio Clinic workflow updates. These developments will be showcased at the Chicago Dental Society Midwinter Meeting in February and the International Dental Show in Cologne in March. Currently, over 150,000 DEXIS dental imaging devices are in use worldwide.

Envista Holdings (NYSE: NVST) has announced its upcoming fourth quarter 2024 financial results release, scheduled for Wednesday, February 5, 2025. The company has rescheduled its conference call to 2:30 PM PT on the same date.

The one-hour earnings call will be accompanied by a slide presentation and webcast available on the 'Investors' section of Envista's website. Participants can join via phone by dialing 800-225-9448 (U.S.) or +1 203-518-9708 (international) using conference ID #7185081. The webcast replay will be accessible for one year, and related materials will be posted on the company's website prior to the call.

Envista Holdings (NYSE: NVST) has scheduled its fourth quarter 2024 earnings conference call for Wednesday, February 5, 2025, at 2:00 PM PT. The call will include a slide presentation and is expected to last approximately one hour.

Investors can access the webcast through the 'Investors' section of www.envistaco.com. A replay will be available for one year following the presentation. For direct dial-in access, participants can call 800-225-9448 (U.S.) or +1 203-518-9708 (international) using conference ID #7185081.

The earnings press release, webcast slides, and related materials will be posted on Envista's website before the conference call.

Envista Holdings (NYSE: NVST) has announced its upcoming participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, from 9:45 – 10:25 am PT at the Westin St. Francis Hotel in San Francisco. An audio-only recording of the presentation will be available on Envista's Investor Relations website for 30 days following the event.

DEXIS showcased its latest AI-powered solutions at the ADF conference in Paris, featuring new intraoral scanners and imaging products. The company presented its ORTHOPANTOMOGRAPH® OP 3D™ EX with customizable field of view and AI-powered software integration. The exhibition also highlighted the IS 3800W wireless scanner, offering ultra-fast impression capture and lightweight design. The company's expanded portfolio aims to enhance diagnostic workflows, increase productivity, and improve patient experience through innovative features like Oral Compare for treatment visualization and SmileFy integration for treatment simulations.

Envista Holdings (NYSE: NVST) has released its 2023 Sustainability Report, highlighting significant progress in ESG initiatives. The report showcases notable achievements including a 26% reduction in Scope 1 greenhouse gas emissions and a 3.5% reduction in total emissions intensity. The company maintained 99% gender and ethnic pay equity in the U.S. and donated nearly $1.3 million through the Envista Smile Project.

The report outlines five key focus areas: Delivering Quality and Access, Supporting People and Community, Safeguarding the Environment, Centering Ethics and Compliance, and Practicing Good Governance. Envista implemented several Kaizen projects to enhance sustainability and operational efficiency in waste generation and energy use.

Envista Holdings (NYSE: NVST) has announced its upcoming participation in a fireside chat at the Evercore HealthCONx Conference. The event will take place on Tuesday, December 3, 2024, from 12:30 – 1:15 pm ET at the Loews Coral Gables Hotel in Coral Gables, Florida. An audio-only recording of the session will be available on Envista's Investor Relations website for up to 365 days after the event.

Envista Holdings (NYSE: NVST) reported Q3 2024 financial results with sales of $601.0 million, showing a core sales decline of 5.3% compared to Q3 2023. Net income decreased to $8.2 million ($0.05 per diluted share) from $21.5 million ($0.12 per diluted share) in Q3 2023. Adjusted net income fell to $21.1 million ($0.12 per diluted share) from $75.5 million ($0.43 per diluted share). Adjusted EBITDA decreased to $54.9 million from $123.5 million year-over-year. The company maintains its full-year 2024 guidance of -1% to -4% core sales growth and adjusted EBITDA margins between 10-12%.

Envista Holdings (NYSE: NVST) has announced its upcoming third quarter 2024 earnings call, scheduled for Wednesday, October 30, 2024. The company will report its financial results and host a conference call beginning at 2:00 PM PT, expected to last about an hour.

Investors can access the call and accompanying slide presentation through a webcast on Envista's website in the "Investors" section. A replay will be available shortly after and remain accessible for one year. For those preferring to dial in, the call can be accessed at 800-225-9448 within the U.S. or +1 203-518-9708 internationally, using conference ID #6240897.

Envista will post its earnings press release, webcast slides, and related presentation materials on the company website's "Investors" section prior to the conference call.